A Randomized Double-Blind, Placebo-Controlled, Multiple-

Project: Research project

Project Details

Description

A Randomized Double-Blind, Placebo-Controlled, Multiple-Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the DeltaF508-CFTR Gene Mutation
StatusFinished
Effective start/end date6/16/095/31/11

Funding

  • Vertex Pharmaceuticals Incorporated

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.